Previous studies have shown that integrin α6β4 dramatically upregulates VEGF expression in breast cancer through inactivation of translation factor inhibitor 4E-binding protein (4E-BP1) [28]. This evidence concerns the gene EIF4EBP1 and breast carcinoma.